Table of Contents 2
List of Tables 5
List of Figures 5
CytomX Therapeutics, Inc. Spshot 6
CytomX Therapeutics, Inc. Overview 6
Key Information 6
Key Facts 6
CytomX Therapeutics, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
CytomX Therapeutics, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
CytomX Therapeutics, Inc. - Pipeline Products Glance 12
CytomX Therapeutics, Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combition Treatment Modalities 12
Discovery Products/Combition Treatment Modalities 13
CytomX Therapeutics, Inc. - Drug Profiles 14
CTX-023 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CTX-033 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
CTX-1003 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CX-072 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CX-2009 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Monoclol Antibody Conjugate to Target CD-71 for Oncology 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Monoclol Antibody Conjugate to Target ITGA-3 for Oncology 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Monoclol Antibody Conjugated to Target CD3 and EGFR for Solid Tumor 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Monoclol Antibody Conjugates 1 for Oncology 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Monoclol Antibody Conjugates 2 for Oncology 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Monoclol Antibody to Antagonize CTLA4 for Oncology 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Cellular Immunotherapy for Oncology 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Monoclol Antibodies 1 for Oncology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Monoclol Antibodies 2 for Oncology 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Monoclol Antibodies for Oncology 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Monoclol Antibody Conjugates 3 for Oncology 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Monoclol Antibody Conjugates for Oncology 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Monoclol Antibody to Antagonize Interleukin-6 Receptor for Inflammation 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Monoclol Antibody to Antagonize PD-1 for Oncology 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Monoclol Antibody to Inhibit Glycoprotein-130 for Inflammation 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
CytomX Therapeutics, Inc. - Pipeline Alysis 34
CytomX Therapeutics, Inc. - Pipeline Products by Target 34
CytomX Therapeutics, Inc. - Pipeline Products by Molecule Type 35
CytomX Therapeutics, Inc. - Pipeline Products by Mechanism of Action 36
CytomX Therapeutics, Inc. - Recent Pipeline Updates 37
CytomX Therapeutics, Inc. - Dormant Projects 39
CytomX Therapeutics, Inc. - Locations And Subsidiaries 40
Head Office 40
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 41
Disclaimer 42